1/16
Looks like no tags are added yet.
More antigen-specific lymphocytes
Long-lived plasma cells in bone marrow
Memory B cells
Memory T cells in lymphoid organs and tissues
Eurasia
Always circulating
30% mortality rate
North American Colonization
90% mortality rate
1900s
~ 300 million deaths
Variolation
Dried smallpox scap powder inhaled or transferred into cuts
Vaccination
Inoculated with cowpox via small poke
Modern vaccination
Infection with live vaccinia virus
Closely related to horsepox
Applied with bifurcated needel
mRNA vaccine
Approach: Inject with mRNA that encodes target antigen
Pros: Can vaccinate against any protein, Easy to modify and update
Cons: Unstable, ultra cold storage
Subunit vaccine
Approach: Administer pathogen protein component paired to adjuvant
Pros: Very stable, no containment requirements
Cons: Need an adjuvant, stable but cannot be frozen, multiple doses required
Live attenuated vaccine
Approach: Infection with related but less harmful pathogen
Pros: 1 dose= strong immune activation, multiple of all epitopes present, activation in relevant tissues
Cons: Storage and transport, can cause disease in susceptible people, can revert to disease-causing form
Inactivated vaccine
Approach: Kill pathogen, then administer
Pros: Stable, easy to store, cannot cause disease
Cons: 3D pathogen structure maintenance is difficult, weaker immune response- booster required
Recombinant (viral) vector vaccine
Approach: Take surface protein from a harmful pathogen, Engineer a harmless virus to express that surface protein
Pros: 1 dose= strong immune activation, fast redesign, some are quaternary stable
Cons: Immune response also against vector (VSV), unstable, ultra cold storage
Toxoid vaccine
Approach: Administer pathogen toxin paired to adjuvant
Pros: Cheapest of all options, well understood (new vaccines require minimal testing)
Cons: Needs an adjuvant, stable but cannot be frozen, injection only, multiple doses required, personal protection (not community)
Conjugate vaccine
Approach: Bacterial sugar attached to carrier protein, immune system treats the sugar like protein, generating a stronger response
Pros: High quality anti-sugar antibodies, Effective in infants, stable storage and shipment
Cons: Many sugars used by different bacteria, use can change, multiple doses needed, difficult to grow and prepare
Vaccine components
Active ingredient/antigens
Adjuvants
Stabilizers
Preservatives
Water, salt, buffers
Deliver ingredients
Manufacturing traces
Herd immunity
R0= average # of people 1 case infects in a susceptible population
Threshold= 1-1/R0
Not everyone can be vaccinated
Immunodeficient
Age (very young/old)
Allergies to vaccine components